Search Results

There are 334068 results for: content related to: Opioids, QTc Prolongation, and Torsades

  1. Clinical Relevance and Management of Drug-Related QT Interval Prolongation

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 7, July 2003, Pages: 881–908, Dr. Michael A. Crouch, Dr. Lynn Limon and Dr. Angela T. Cassano

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.7.881.32730

  2. Risk Assessment for Antimicrobial Agent-Induced QTc Interval Prolongation and Torsades de Pointes

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 3, March 2001, Pages: 301–319, Robert C. Owens Jr.

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.3.301.34206

  3. Long QTc and Torsades de Pointes in Human Immunodeficiency Virus Disease

    Pacing and Clinical Electrophysiology

    Volume 20, Issue 11, November 1997, Pages: 2810–2816, ABRAHAM G. KOCHERIL, S.A.J. BOKHARI, WILLIAM P. BATSFORD and ALBERT J. SINUSAS

    Version of Record online : 30 JUN 2006, DOI: 10.1111/j.1540-8159.1997.tb05439.x

  4. Prevalence and determinants of QT interval prolongation in medical inpatients

    Internal Medicine Journal

    Volume 42, Issue 8, August 2012, Pages: 933–940, M. Pasquier, O. Pantet, O. Hugli, E. Pruvot, T. Buclin, G. Waeber and D. Aujesky

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1445-5994.2011.02447.x

  5. You have full text access to this OnlineOpen article
    The Effect of Intravenous Haloperidol on QT Interval Dispersion in Critically Ill Patients: Comparison with QT Interval Prolongation for Assessment of Risk of Torsades de Pointes

    The Journal of Clinical Pharmacology

    Volume 41, Issue 12, December 2001, Pages: 1310–1318, Dr. James E. Tisdale, Dr. Saeed Rasty, Dr. I. Desmond Padhi, Dr. Nagaraja D. Sharma and Dr. Howard Rosman

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912700122012896

  6. You have free access to this content
    The role of the Na+/Ca2+ exchanger, INa and ICaL in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts

    British Journal of Pharmacology

    Volume 156, Issue 6, March 2009, Pages: 920–932, Attila S Farkas, Péter Makra, Norbert Csík, Szabolcs Orosz, Michael J Shattock, Ferenc Fülöp, Tamás Forster, Miklós Csanády, Julius Gy Papp, András Varró and András Farkas

    Version of Record online : 16 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00096.x

  7. You have free access to this content
    Clinically relevant QTc prolongation due to overridden drug–drug interaction alerts: a retrospective cohort study

    British Journal of Clinical Pharmacology

    Volume 67, Issue 3, March 2009, Pages: 347–354, Heleen Van Der Sijs, Ravi Kowlesar, A. Peter J. Klootwijk, Stefan P. Nelwan, Arnold G. Vulto and Teun Van Gelder

    Version of Record online : 10 DEC 2008, DOI: 10.1111/j.1365-2125.2008.03357.x

  8. You have free access to this content
    Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias

    Cardiovascular Therapeutics

    Volume 33, Issue 3, June 2015, Pages: 127–133, Mohsin Chowdhury, Jason Wong, Angela Cheng, Michael Khilkin and Eugen Palma

    Version of Record online : 12 MAY 2015, DOI: 10.1111/1755-5922.12120

  9. You have free access to this content
    Torsades de pointes caused by Mibefradil

    European Journal of Heart Failure

    Volume 3, Issue 5, October 2001, Pages: 627–630, Sven Gläser, Michaela Steinbach, Christian Opitz, Ullrich Wruck and Franz X. Kleber

    Version of Record online : 15 OCT 2001, DOI: 10.1016/S1388-9842(01)00159-3

  10. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system

    Pharmacoepidemiology and Drug Safety

    Volume 14, Issue 11, November 2005, Pages: 747–753, Ellen C. Pearson and Raymond L. Woosley

    Version of Record online : 25 MAY 2005, DOI: 10.1002/pds.1112

  11. You have free access to this content
    The FDA extended warning for intravenous haloperidol and torsades de pointes: How should institutions respond?

    Journal of Hospital Medicine

    Volume 5, Issue 4, April 2010, Pages: E8–E16, Carla Meyer-Massetti, Christine M Cheng, Bradley A Sharpe, Christoph R Meier and B. Joseph Guglielmo

    Version of Record online : 8 APR 2010, DOI: 10.1002/jhm.691

  12. Lack of Electrocardiographic Effect of Dexlansoprazole MR, a Novel Modified-Release Formulation of the Proton Pump Inhibitor Dexlansoprazole, in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 12, December 2009, Pages: 1447–1455, Majid Vakily, Jingtao Wu and Stuart N. Atkinson

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009339188

  13. QT Interval Prolongation and Torsades de Pointes Unmasked by Intracoronary Acetylcholine Administration

    Pacing and Clinical Electrophysiology

    Volume 24, Issue 10, October 2001, Pages: 1561–1562, MASAOMI CHINUSHI, IWAO NAKAGAWA, TOMOYUKI HORI, FUMIO YAMASHITA, TAKASHI WASHIZUKA and YOSHIFUSA AIZAWA

    Version of Record online : 22 JUL 2003, DOI: 10.1046/j.1460-9592.2001.01561.x

  14. Dofetilide-Induced Long QT and Torsades de Pointes

    Annals of Noninvasive Electrocardiology

    Volume 12, Issue 3, July 2007, Pages: 197–202, Mehmet K. Aktas, Abrar H. Shah and Toshio Akiyama

    Version of Record online : 5 JUL 2007, DOI: 10.1111/j.1542-474X.2007.00161.x

  15. You have free access to this content
    Key clinical considerations for demonstrating the utility of preclinical models to predict clinical drug-induced torsades de pointes

    British Journal of Pharmacology

    Volume 154, Issue 7, August 2008, Pages: 1544–1549, P T Sager

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.222

  16. Fatal Dysrhythmia Following Initiation of Lansoprazole During a Long-Term Course of Voriconazole

    The Journal of Clinical Pharmacology

    Volume 51, Issue 10, October 2011, Pages: 1488–1490, Dr Masaharu Tsubokura, Dr Yuji Miura, Dr Tatsuo Itokawa, Dr Kazuhiro Murata, Dr Naoko Takei, Dr Tadanao Higaki, Dr Naoko Murashige, Dr Masahiro Kami and Dr Tsunehiko Komatsu

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010384483

  17. Torsades de Pointes Associated with Chlorpromazine: Case Report and Review of Associated Ventricular Arrhythmias

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 7, July 2001, Pages: 871–883, Dr. James D. Hoehns, Dr. Richard H. Stanford, Dr. Douglas R. Geraets, Dr. Kelly S. Skelly, Dr. Hon-Chi Lee and Dr. Brian L. Gaul

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.9.871.34565

  18. Predictive Factors of Ventricular Fibrillation Triggered by Pause-Dependent Torsades de Pointes Associated with Acquired Long QT Interval:

    Journal of Cardiovascular Electrophysiology

    Volume 11, Issue 9, September 2000, Pages: 990–997, ANTOTNE DA COSTA, THIERRY CHALVIDAN, ALI BELOUNAS, MARC MESSIER, MICHEL VIALLET, HASSAN MANSOUR, DOMINIQUE LAMAISON, PIERRE DJIANE and KARL ISAAZ

    Version of Record online : 20 APR 2007, DOI: 10.1111/j.1540-8167.2000.tb00171.x

  19. You have free access to this content
    Investigation of mechanism of drug-induced cardiac injury and torsades de pointes in cynomolgus monkeys

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2771–2786, DL Misner, C Frantz, L Guo, MR Gralinski, PB Senese, J Ly, M Albassam and KL Kolaja

    Version of Record online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01756.x

  20. QTc prolongation and diabetes therapies

    Diabetic Medicine

    Volume 29, Issue 3, March 2012, Pages: 290–292, K. Watters, N. Munro and M. Feher

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1464-5491.2011.03520.x